Pirarubicin - Amerigo Scientific

- Overview
  - Antibiotic of anthracycline class; DNA synthesis inhibitor
    
    Please contact us at for specific academic pricing.
- Properties
  - Categories
    
    Antibiotics
    
    Alternative Name
    
    (8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trih ydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
    
    CAS Number
    
    72496-41-4
    
    Molecular Formula
    
    C32H37NO12
    
    Molecular Weight
    
    627.64 g/mol
    
    MDL Number
    
    MFCD28988956
    
    Note
    
    There is no hazardous surcharge associated with this product.
    There is no special packaging charge associated with this product.
    
    * For research use only. Not for human or veterinary use
- Reference
  - Umezawa (1979) Tetrahydropyranyl derivatives of daunomycin and adriamycin. Journal of Antibiotics. 32(10):1082-4.
    Majima (1987) Clinical studies of (2R)-4-O-tetrahydropyranyl adriamycin (THP). Biomedicine & Pharmacotherapy. 41(5):237-43.
    Miller (1987) Clinical pharmacology and toxicity of 4-O-tetrahydropyranyladriamycin. Cancer Research. 47(5):1461-5.
    Fallik (2003) Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer. Annals of Oncology. 14(6):856-63.